Duloxetine (DL) in treatment of oxaliplatin-induced peripheralneuropathy (PN)

Authors
Category Primary study
JournalJournal of clinical oncology
Year 2021
This article has no abstract
Epistemonikos ID: ab3d86b27debf9ed35ac18e0ea254e4073e7f4f2
First added on: Feb 01, 2023